ESR1 and breast cancer: The exact definition of basal-like breast cancer (BLBC) is a topic of debate, but the title was initially designated to tumors characterized by an expression of markers for basal epithelial cells including cytokeratins (CK) 5/6 and CK17 with low or negative ER expression [12].